Amycretin, an oral weight loss drug, led to up to 13% body weight reduction in three months, showing potential for continued ...

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better ...

Kourtney Kardashian showcased her new signature product, which she describes as a "breakthrough innovation" in weight loss ...

As Novo Nordisk A/S and Eli Lilly and Co. go head-to-head in the U.S. and Chinese glucagon-like peptide-1 receptor agonists ...

Some people lose more weight on drugs like Ozempic, Wegovy and Saxenda than others, and a new study reveals why that might be.

Page Six exclusively spoke with a registered dietitian about the safety and efficiency of the “Kardashians” star’s latest ...

According to a recent poll, one in eight American adults report that they have used a glucagon-like peptide-1 agonist ...

French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and ...

Data from the US FDA's Adverse Event Reporting System on tirzepatide showed adverse events generally consistent with those ...

Recently, the spotlight on weight management and metabolic health has intensified, partly due to the rise of GLP-1 (glucagon-like peptide-1) medications like Ozempic and Wegovy. These drugs, ...

As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns ...

If you were prescribed a GLP-1, it's important that you understand how your insurance coverage works in order to stay on top ...